Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Cocaine use disorder affects millions globally, posing significant public health risks.
• Chronic cocaine use is linked to cerebral, cardiovascular, and neurodegenerative disorders.
• Increased risk of antipsychotic-induced extrapyramidal symptoms (EPSs) is observed in patients with comorbid psychotic disorders and psychostimulant misuse.

Observation:

• A case study details a young patient with prior cocaine misuse experiencing rapid psychomotor symptoms.
• The patient showed poor response to standard treatments like benzodiazepines and anticholinergics.
• Symptoms emerged following the introduction of various antipsychotic medications.

Findings:

• Chronic cocaine administration induces neurobiological changes, dysregulating neurotransmitter systems.
• Subcortical structures, particularly dopaminergic and glutamatergic pathways, are significantly affected.
• These changes may underlie an increased vulnerability to psychomotor symptoms in chronic cocaine abusers.

Implications:

• Understanding these neurobiological mechanisms is crucial for clinical practice.
• This knowledge can guide pharmacological choices to improve the risk-benefit ratio.
• Improved treatment strategies are needed for patients with comorbid psychotic disorders and substance use disorders.